TB: It Takes More than a Village to Raise a Remedy

8th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer Dr. Clifton E. Barry received his Ph.D. degree in organic and bioorganic chemistry in 1989 from Cornell University, and then was a postdoctoral fellow in the department of chemistry at the Johns Hopkins University. In 1991, he joined the NIH intramural research program as an investigator at the Rocky Mountain Laboratories, studying DNA-protein interactions during chlamydial development. In 1993 he established the Mycobacterial Research Unit that initially studied mycolic acid biosynthesis in Mycobacterium tuberculosis. In 1998, he was tenured as a Senior Investigator of the Tuberculosis Research Section (TRS) and relocated his laboratory to the Bethesda area. The TRS is a multidisciplinary group of research scientists comprised of biologists, chemists and clinical researchers who share a common interest in TB. TRS projects focus on understanding the scientific issues that facilitate the development of drugs that will make a genuine difference in the outcome for TB patients globally. TRS scientists are highly interactive worldwide in this endeavor and as a result of our outstanding collaborations TRS is the most widely cited TB research group in the world. In addition to current TRS laboratories in Bethesda TRS works closely with the International Tuberculosis Research Center located in Masan, South Korea; with Chinese colleagues at the Henan Provincial Chest Hospital in Zheng...
Source: Videocast - All Events - Category: Journals (General) Tags: Upcoming Events Source Type: video